Related Experiment Video

Updated: Aug 8, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Markers for early detection of cardiac diseases

Alan H B Wu1

  • 1Department of Laboratory Medicine University of California, San Francisco, CA, USA. awu@harthosp.org

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|August 23, 2005
PubMed

Insights

New biomarkers show promise for early detection of acute coronary syndromes (ACS) in emergency departments. These novel markers may aid in timely diagnosis and treatment decisions for patients presenting with chest pain.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Emergency Medicine

Background:

  • Current myocardial necrosis markers (troponin, CK-MB, myoglobin) are often negative in early acute coronary syndromes (ACS).
  • Timely diagnosis and risk stratification are crucial for patients presenting to the emergency department (ED) within 3 hours of chest pain onset.
  • Existing biomarkers lack the sensitivity for early ACS detection, necessitating research into novel diagnostic tools.

Purpose of the Study:

  • To identify and evaluate novel biomarkers for the early diagnosis and risk stratification of acute coronary syndromes (ACS).
  • To explore potential new diagnostic markers that can be utilized during initial emergency department (ED) presentations.

Main Methods:

  • Review of active research identifying several classes of promising biomarkers for early ACS detection.
  • Categorization of novel biomarkers based on their proposed mechanism: inflammation, plaque instability, platelet activation, and myocardial ischemia.
  • Assessment of the utility of each biomarker class in diagnosing ACS during the critical early hours.

Main Results:

  • Several classes of biomarkers show potential for early ACS detection, including those related to inflammation (hs-CRP, MPO), plaque instability (PAPP-A, PGF), platelet activation (whole blood choline, CD40L), and ischemia (IMA, FFAs, serum choline, BNP).
  • Each investigated biomarker class demonstrated some diagnostic utility for early ACS identification.
  • No single novel biomarker currently possesses sufficient specificity for routine myocardial disease diagnosis.

Conclusions:

  • Novel biomarkers offer potential for improved early diagnosis and risk stratification of acute coronary syndromes (ACS).
  • A multi-marker approach may be necessary to enhance diagnostic accuracy and specificity for myocardial disease.
  • Further research and validation are required for the routine clinical application of these promising biomarkers.

More Related Videos

Ultrasonic Assessment of Myocardial Microstructure10:53

Ultrasonic Assessment of Myocardial Microstructure

Published on: January 14, 2014

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...